VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Men and women older than 18 years, scheduled       │ Men and women older than 18 years, scheduled       │     100 │
│ consecutively to perform a coronary procedure in   │ consecutively to perform a coronary procedure in   │         │
│ the department of hemodynamics of the National     │ the department of hemodynamics of the National     │         │
│ Institute of Cardiology "Ignacio Chavez"           │ Institute of Cardiology "Ignacio Chavez"           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients may have any of the following indications │ Patients may have any of the following indications │     100 │
│ for cardiac catheterization: Thoracic pain under   │ for cardiac catheterization: Thoracic pain under   │         │
│ study. Stable chronic coronary disease. Acute      │ study. Stable chronic coronary disease. Acute      │         │
│ myocardial infarction with ST segment elevation,   │ myocardial infarction with ST segment elevation,   │         │
│ not perfused (without timely reperfusion therapy)  │ not perfused (without timely reperfusion therapy)  │         │
│ with less than 4 weeks of evolution. Acute         │ with less than 4 weeks of evolution. Acute         │         │
│ myocardial infarction with ST-segment elevation,   │ myocardial infarction with ST-segment elevation,   │         │
│ successful thrombolytic therapy, which will        │ successful thrombolytic therapy, which will        │         │
│ undergo drug-invasive therapy. Acute myocardial    │ undergo drug-invasive therapy. Acute myocardial    │         │
│ infarction without ST segment elevation. Unstable  │ infarction without ST segment elevation. Unstable  │         │
│ angina. Any acute coronary syndrome, to intervene  │ angina. Any acute coronary syndrome, to intervene  │         │
│ non-infarct-related artery. Disease of any heart   │ non-infarct-related artery. Disease of any heart   │         │
│ valve. Myocarditis or pericarditis. Dilated        │ valve. Myocarditis or pericarditis. Dilated        │         │
│ cardiomyopathy. Patients in renal or cardiac       │ cardiomyopathy. Patients in renal or cardiac       │         │
│ transplantation protocol for any etiology.         │ transplantation protocol for any etiology.         │         │
│ Congenital heart disease that requires knowing the │ Congenital heart disease that requires knowing the │         │
│ coronary anatomy prior to surgical correction      │ coronary anatomy prior to surgical correction      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ The planned procedure can be any of the following: │ The planned procedure can be any of the following: │     100 │
│ For diagnostic purposes (coronary angiography      │ For diagnostic purposes (coronary angiography      │         │
│ only, left catheterization, left and right         │ only, left catheterization, left and right         │         │
│ catheterization). For therapeutic purposes:        │ catheterization). For therapeutic purposes:        │         │
│ percutaneous coronary intervention (PCI), with or  │ percutaneous coronary intervention (PCI), with or  │         │
│ without stent placement                            │ without stent placement                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ A priori access must be right or left radial       │ A priori access must be right or left radial       │     100 │
│ artery                                             │ artery                                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Radial arterial pulse may be present or absent by  │ Radial arterial pulse may be present or absent by  │     100 │
│ palpation                                          │ palpation                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Modified Allen or Barbeau test should be positive  │ Modified Allen or Barbeau test should be positive  │     100 │
│ (presence of collateral palmar flow)               │ (presence of collateral palmar flow)               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant                                           │ Pregnant                                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Not have informed consent for the present clinical │ Not have informed consent for the present clinical │     100 │
│ trial, or do not fully understand the meaning of   │ trial, or do not fully understand the meaning of   │         │
│ informed consent                                   │ informed consent                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ With acute myocardial infarction with ST segment   │ With acute myocardial infarction with ST segment   │     100 │
│ elevation in the first 12 hours from the onset of  │ elevation in the first 12 hours from the onset of  │         │
│ symptoms                                           │ symptoms                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ With any acute coronary syndrome complicated with  │ With any acute coronary syndrome complicated with  │     100 │
│ acute pulmonary edema, cardiogenic shock and / or  │ acute pulmonary edema, cardiogenic shock and / or  │         │
│ malignant ventricular arrhythmias                  │ malignant ventricular arrhythmias                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ In which a cardiac catheterization is planned a    │ In which a cardiac catheterization is planned a    │     100 │
│ priori to be performed via femoral, brachial or    │ priori to be performed via femoral, brachial or    │         │
│ ulnar                                              │ ulnar                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients in whom first attempt of arterial         │ Patients in whom first attempt of arterial         │     100 │
│ puncture is performed by 2nd year interventional   │ puncture is performed by 2nd year interventional   │         │
│ cardiology fellow or by physician in charge        │ cardiology fellow or by physician in charge        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Participating in another clinical trial            │ Participating in another clinical trial            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Be allergic or have contraindications to           │ Be allergic or have contraindications to           │     100 │
│ nitroglycerin or other nitrates                    │ nitroglycerin or other nitrates                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any phosphodiesterase 5 inhibitor (sildenafil,     │ Any phosphodiesterase 5 inhibitor (sildenafil,     │     100 │
│ tadalafil, avanafil, vardenafil) has been taken    │ tadalafil, avanafil, vardenafil) has been taken    │         │
│ within 72 hours prior to the study                 │ within 72 hours prior to the study                 │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                │   Score │
╞═══════════════════════════════════╪══════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ A priori access must be right or left radial │      36 │
│                                   │ artery                                       │         │
╘═══════════════════════════════════╧══════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 99
Average Levenshtein Ratio of individual lines: 96.0
OverAll Ratio: 97.5
